Our California clinics provide a specialized, rapid-acting approach for residents seeking a "different pathway" to healing. We offer Spravato® (esketamine) in a medically supervised, comfortable environment, specifically designed for adults who have not found relief through standard oral antidepressants. From the coastal beauty of San Diego to the busy corridors of Los Angeles, our clinics allow patients to access life-changing care without the need for invasive procedures.
The California clinical teams focuses on achieving rapid symptom relief by targeting the brain's glutamate system and NMDA receptors. Unlike traditional medications that can take weeks to work, Spravato often begins to alleviate depressive symptoms within hours or days. Our facilities are strategically located near major hubs—including La Jolla Village Drive in San Diego and central locations in Orange County—ensuring that high-quality interventional psychiatry is easily accessible via major highways like Interstates 5 and 405.
California law and FDA regulations require Spravato to be administered only in certified REMS (Risk Evaluation and Mitigation Strategy) settings. Our clinics adhere to these rigorous standards, with licensed psychiatric professionals overseeing every treatment and monitoring patients for at least two hours post-administration to manage any temporary side effects like dissociation or blood pressure changes.
Clinical teams in California serves diverse communities from convenient locations in San Diego, Huntington Beach, Torrance, and Laguna Hills. Providing local access to this technology helps patients avoid the stress of long commutes across the state's sprawling metro areas. Appointment schedules are optimized to fit into busy California lifestyles, with some locations offering extended hours from 7 AM to 7 PM to ensure you can stay consistent with your care plan. Individuals are encouraged to explore clinical outcomes and the specialized patient experience at our California centers to prepare for their evaluation.
Yes, Spravato is FDA-approved and has a well-established safety profile. In our California clinics, patients are strictly monitored by healthcare professionals for at least two hours to manage transient side effects such as sedation or dissociation.
Yes, we have a robust network of clinics throughout Southern California, including specialized hubs in San Diego, Los Angeles, Orange County, and Riverside.
Most major California insurance providers, including Kaiser, Blue Shield of California, and Anthem, cover Spravato. Our staff will help you verify coverage and explore patient assistance programs that can reduce out-of-pocket costs to as little as $10 per treatment.
Clinical teams typically follows a structured schedule: twice-weekly sessions for the first 4 weeks (Induction), followed by once-weekly sessions for the next 4 weeks (Optimization).
Our California facilities primarily treat adults with Treatment-Resistant Depression (TRD) and Major Depressive Disorder (MDD) with acute suicidal ideation or behavior.
Yes, a referral is generally required to confirm a diagnosis of Treatment-Resistant Depression (TRD), meaning you have not responded to at least two different oral antidepressants.
